HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF

Provided is 5-(3-chloro-4-fluorophenyl)-7-cyclopropyl-3-(2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl)-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one and pharmaceutically acceptable salts thereof, and their uses in the treatment of psychiatric, neurological, and neurodevelopmental disorders, as well...

Full description

Saved in:
Bibliographic Details
Main Authors PISER, Timothy, LEISER, Steven, C, KEANEY, Gregg, F, VOLKMANN, Robert, A, MALEKIANI, Sam, ANDERSON, David, R
Format Patent
LanguageEnglish
Published 31.05.2023
Online AccessGet full text

Cover

More Information
Summary:Provided is 5-(3-chloro-4-fluorophenyl)-7-cyclopropyl-3-(2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl)-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one and pharmaceutically acceptable salts thereof, and their uses in the treatment of psychiatric, neurological, and neurodevelopmental disorders, as well as diseases of the nervous system.
Bibliography:Application Number: ZA20210001273